These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Unraveling the Regulation of Hepatic Metabolism by Insulin. Titchenell PM; Lazar MA; Birnbaum MJ Trends Endocrinol Metab; 2017 Jul; 28(7):497-505. PubMed ID: 28416361 [TBL] [Abstract][Full Text] [Related]
3. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Bo T; Gao L; Yao Z; Shao S; Wang X; Proud CG; Zhao J Cell Metab; 2024 May; 36(5):947-968. PubMed ID: 38718757 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of selective insulin resistance in isolated hepatocytes. Cook JR; Langlet F; Kido Y; Accili D J Biol Chem; 2015 May; 290(22):13972-80. PubMed ID: 25873396 [TBL] [Abstract][Full Text] [Related]
5. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux. Otero YF; Stafford JM; McGuinness OP J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277 [TBL] [Abstract][Full Text] [Related]
6. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences. Hijmans BS; Grefhorst A; Oosterveer MH; Groen AK Biochimie; 2014 Jan; 96():121-9. PubMed ID: 23792151 [TBL] [Abstract][Full Text] [Related]
7. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Farese RV; Sajan MP; Standaert ML Exp Biol Med (Maywood); 2005 Oct; 230(9):593-605. PubMed ID: 16179727 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in the liver: deficiency or excess of insulin? Bazotte RB; Silva LG; Schiavon FP Cell Cycle; 2014; 13(16):2494-500. PubMed ID: 25486190 [TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Samuel VT; Shulman GI J Clin Invest; 2016 Jan; 126(1):12-22. PubMed ID: 26727229 [TBL] [Abstract][Full Text] [Related]
12. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637 [TBL] [Abstract][Full Text] [Related]
13. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. Fisher SJ; Kahn CR J Clin Invest; 2003 Feb; 111(4):463-8. PubMed ID: 12588884 [TBL] [Abstract][Full Text] [Related]
14. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. Vatner DF; Majumdar SK; Kumashiro N; Petersen MC; Rahimi Y; Gattu AK; Bears M; Camporez JP; Cline GW; Jurczak MJ; Samuel VT; Shulman GI Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1143-8. PubMed ID: 25564660 [TBL] [Abstract][Full Text] [Related]